3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Active not recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Uterine Cervical Neoplasms
6
Esophageal Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Nasopharyngeal Carcinoma
5
Lung Neoplasms
5
Nasopharyngeal Neoplasms
3
Esophageal Squamous Cell Carcinoma
3
Breast Neoplasms
3
Neoplasms, Germ Cell and Embryonal
2
Head and Neck Neoplasms
2
Gallbladder Neoplasms
2
Carcinoma, Squamous Cell
2
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Recurrence
1
Ovarian Neoplasms
1
Oesophagogastric Cancer
1
Neoplasms, Squamous Cell
1
Neoplasm Metastasis
1
Mesothelioma, Malignant
1
Locally Advanced Cervical Cancer
1
Human Papillomavirus (HPV)-Positive Oropharyngeal Cancer
1
Gastro-enteropancreatic neuroendocrine tumor
1
Fibrosis Of Extraocular Muscles, Congenital, 3A, with or without Extraocular Involvement
1
Endometrial Neoplasms
1
EGFR Positive Non-small Cell Lung Cancer
1
Carcinoma, Ovarian Epithelial
1
Interventions
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Human Papillomavirus (HPV)-Positive Oropharyngeal Cancer
×
Cisplatin
×
Clear all
NCT02215265
2025-02-19
PATHOS
Velindre NHS Trust
Phase 3
Active not recruiting
1,269 enrolled